MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Beneficial and protective effects of Terminalia chebula in a murine model of Parkinson’s disease

A. Kumar, S. Farhat (New Delhi, India)

Meeting: 2019 International Congress

Abstract Number: 940

Keywords: 1-Methyl-4-phenylpyridinium (MPP+), Drug-induced parkinsonism(DIP), Oxidative stress

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: Present study was designed to investigate whether Terminalia chebula (TC) extract would prevent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)  induced neurotoxicity in male Wistar rats.

Background: Parkinson’s disease (PD) is a major neurological disorder known since ancient times. It is characterized by signs of major oxidative stress and mitochondrial damage in the pars compacta of substantia nigra.

Method: MPTP was stereotaxically injected into the substantia nigra pars compacta  of male Wistar rats. Male Wistar rats were divided into following five groups: Group I received vehicle (saline (10 ml/kg for 21 days) orally); Group II received TC extract (200 mg/kg for 21 days) orally; Group III was treated with 20 mg/kg MPTP i.p. for 21 days; Group IV received 20 mg/kg MPTP, i.p. along with 200 mg/kg TC orally for 21 days. Group V received 20 mg/kg MPTP i.p. along with 400 mg/kg TC orally for 21 days.  And then, the rats were sacrificed for further studies.

Results: The mice treated with MPTP developed motor dysfunction and behavioral alterations similar to PD, which was tested with rotarod test, and hang test which revealed the impaired performance, working memory, object recognition, reduced neurogenesis and impaired neuromuscular strength respectively. Group III rats elicited significant increase in lipid peroxidation along with reduction in level of antioxidant enzymes and total antioxidants. Histological data revealed that MPTP treated rats shown pathological changes like cellular inflammation and vascular degeneration in brain tissue. Treatment with TC extract reversed the motor dysfunction, antixodant enzymes, lipid peroxidation  significantly in a dose dependent manner. The  Bcl-2/Bax gene expression ratio and protein expression of brain derived neurophic factor (BDNF)  were significantly increased in TC treated groups.

Conclusion: TC by its antioxidant property has a neuroprotective activity both in motor activity and behaviourally in the MPTP induced Parkinson disease in mice.

To cite this abstract in AMA style:

A. Kumar, S. Farhat. Beneficial and protective effects of Terminalia chebula in a murine model of Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/beneficial-and-protective-effects-of-terminalia-chebula-in-a-murine-model-of-parkinsons-disease/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/beneficial-and-protective-effects-of-terminalia-chebula-in-a-murine-model-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley